DJ Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Wednesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ shed 1.25% to $18.91 Wednesday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index rising 2.95% to 18,983.47 and the Dow Jones Industrial Average rising 3.57% to 43,729.93.
The stock's fall snapped a three-day winning streak.
Corbus Pharmaceuticals Holdings Inc. closed $42.99 below its 52-week high ($61.90), which the company reached on July 31st.
The stock underperformed when compared to some of its competitors Wednesday, as Vanda Pharmaceuticals Inc. $(VNDA)$ rose 2.09% to $4.89, Fortress Biotech Inc. (FBIO) fell 0.28% to $1.76, and Viking Therapeutics Inc. $(VKTX)$ rose 1.92% to $65.87.
Trading volume (283,769) remained 474,204 below its 50-day average volume of 757,973.
Data source: Dow Jones Market Data, FactSet. Data compiled November 6, 2024.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
November 06, 2024 17:25 ET (22:25 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments